A total of 25% of cases of this group were represented as T-cell ALL which characteristically expressed CD5, surface CD3 (sCD3) and CD4/CD8 dichotomy markers (Fig. 1). The gene discussed is CD5; the disease is T-cell acute lymphoblastic leukemia.